User menu

A phase I/II, multiple-dose, dose-escalation study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with advanced solid tumors

Bibliographic reference Angevin, Eric ; Tabernero, Josep ; Elez, Elena ; Cohen, Steven J ; Bahleda, Rastilav ; et. al. A phase I/II, multiple-dose, dose-escalation study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with advanced solid tumors. In: Clinical Cancer Research, Vol. 20, no.8, p. 2192-2204 (2014)
Permanent URL http://hdl.handle.net/2078.1/147209